Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Update on Cipla and Amgen reach a settlement on pending litigation involving generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg) 20th Jul 2020 Allotment of 37,102 equity shares under ESOS 16th Jul 2020 Notice of Board Meeting – Newspaper Publication 16th Jul 2020 Notice of Board Meeting – August 2020 15th Jul 2020 Press release - Cipla receives final approval for generic version of Shire’s Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL) 14th Jul 2020 Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix for Development and Commercialization of Pulmazole 13th Jul 2020 Schedule of Analyst / Institutional Investor Meetings 29th Jun 2020 Press Release – Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs 29th Jun 2020 Schedule of Analyst and Institutional Investors meetings 26th Jun 2020 Schedule of Analyst and Institutional Investors meetings 23rd Jun 2020 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
